Skip to main content

Table 1 Summary of coding for discrete choice experiment attributes and their levels

From: What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial

Attributes

Attribute levels

Variable names

 

Surgery

Imiquimod cream

Current situation

 

1) Cost [cost to you]

£0

£0

£0

COST

 

£150

£150

  
 

£300

£300

  
 

£500

£500

  
 

£750

£750

  

2) Chance [Chance ofcomplete clearance]

94%

50%

96%

CHANCE

 

96%

70%

  
 

98%

90%

  

3) Side effects

MILD

MILD

MILD

MILD SIDE EFFECTS

 

(mild pain that doesnot disturb sleep)

(Mild irritation,burning or redness)

(mild pain that doesnot disturb sleep)

 
 

MODERATE

MODERATE

 

MODERATE SIDE EFFECTS

 

(pain that sometimesmight disturb sleep)

(Moderate irritation, burning,redness or weeping)

  
 

SEVERE

SEVERE

 

(compared with severe)

 

(pain that disturbs sleep)

(Severe irritation, burning,redness or ulceration)

  

4) Appearance

NORMAL

NORMAL

MODERATE CHANGE

NORMAL APPEARANCE

 

(Barely visible scar)

(Not discoloured skin)

(noticeable scar)

 
 

MODERATE CHANGE

MODERATE CHANGE

 

MODERATE CHANGE IN APPEARANCE

 

(Noticeable scar)

(Slight lightening skin)

  
 

SEVERE CHANGE

SEVERE CHANGE

 

(compared with severe change)

 

(Slightly raised scar)

(Discoloured skin)

  

ALTERNATIVES

SURGERY

IMIQUIMOD CREAM

CURRENT SITUATION

SURGERY

   

(fixed surgery option fromtheir experience alternativeto an hypothetical ‘surgery’)

CREAM(compared withcurrent situation)